Xinxin Yu

Gheorghe Comanici, Eric Bieber, Mike Schaekermann et al. · amazon-science, baidu

In this report, we introduce the Gemini 2.X model family: Gemini 2.5 Pro and Gemini 2.5 Flash, as well as our earlier Gemini 2.0 Flash and Flash-Lite models. Gemini 2.5 Pro is our most capable model yet, achieving SoTA performance on frontier coding and reasoning benchmarks. In addition to its incredible coding and reasoning skills, Gemini 2.5 Pro is a thinking model that excels at multimodal understanding and it is now able to process up to 3 hours of video content. Its unique combination of long context, multimodal and reasoning capabilities can be combined to unlock new agentic workflows. Gemini 2.5 Flash provides excellent reasoning abilities at a fraction of the compute and latency requirements and Gemini 2.0 Flash and Flash-Lite provide high performance at low latency and cost. Taken together, the Gemini 2.X model generation spans the full Pareto frontier of model capability vs cost, allowing users to explore the boundaries of what is possible with complex agentic problem solving.

Kesheng Wang, Xiaoyu Chen, Chunlei He et al.

In the medical image analysis field, precise quantification of curve tortuosity plays a critical role in the auxiliary diagnosis and pathological assessment of various diseases. In this study, we propose a novel framework for tortuosity quantification and demonstrate its effectiveness through the evaluation of meibomian gland atrophy uniformity,serving as a representative application scenario. We introduce an information entropy-based tortuosity quantification framework that integrates probability modeling with entropy theory and incorporates domain transformation of curve data. Unlike traditional methods such as curvature or arc-chord ratio, this approach evaluates the tortuosity of a target curve by comparing it to a designated reference curve. Consequently, it is more suitable for tortuosity assessment tasks in medical data where biologically plausible reference curves are available, providing a more robust and objective evaluation metric without relying on idealized straight-line comparisons. First, we conducted numerical simulation experiments to preliminarily assess the stability and validity of the method. Subsequently, the framework was applied to quantify the spatial uniformity of meibomian gland atrophy and to analyze the difference in this uniformity between \textit{Demodex}-negative and \textit{Demodex}-positive patient groups. The results demonstrated a significant difference in tortuosity-based uniformity between the two groups, with an area under the curve of 0.8768, sensitivity of 0.75, and specificity of 0.93. These findings highlight the clinical utility of the proposed framework in curve tortuosity analysis and its potential as a generalizable tool for quantitative morphological evaluation in medical diagnostics.